| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −0.4× | −1.7× | |
| Price / Book | 0.8× | 2.0× | |
| Price / Sales | 7.0× | 3.9× | |
| Price / Free cash flow | −0.4× | −1.6× | |
| EV / EBITDA | −0.2× | −1.2× | |
| Earnings yield | −285.6% | −14.3% | |
| Free cash flow yield | −273.3% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,288.04 | +3.85% | $1.21T | 56.6× | 77.8% | +15.2% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $259.14 | +2.11% | $624.5B | 22.8× | 32.9% | +32.1% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $288.64 | +2.11% | $510.06B | 118.2× | −129.2% | +24.6% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $420.30 | +3.30% | $377.26B | 30.3× | 12.8% | +14.1% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $148.41 | +3.32% | $366.14B | 19.4× | 34.7% | +71.2% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $153.43 | +2.15% | $282.85B | 19.7× | 30.5% | +14.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $168.73 | +2.92% | $261.68B | 24.8× | 21.1% | −2.4% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $690.37 | +1.62% | $255.26B | 37.3× | 12.6% | +26.6% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $435.79 | +2.55% | $235.6B | 29.8× | 89.1% | +43.7% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $156.09 | +1.97% | $193.54B | 22.3× | 37.5% | +29.9% |
